Vinorelbine treatment of recurrent salivary gland carcinomas

Bulletin du Cancer

Volumn 85, Issue 10, 1998, Pages 892-894

  Airoldi, Mario ^a   Bumma, Cesare ^a   Bertetto, Oscar ^a   Gabriele, Pietro ^b   Succo, Giovanni ^c   Pedani, Fulvia ^a  

^a Serv Surg Oncol/Biomed Technol   (Italy)

^b Umbecco I Maximiniano Hop L ^*  (Italy)

^c UNIVERSITY OF TURIN   (Italy)

Author keywords

Chemotherapy; Salivary gland tumors; Vinorelbine

Indexed keywords

MITOXANTRONE; NAVELBINE;

ADULT; ARTICLE; BONE METASTASIS; CANCER CHEMOTHERAPY; CLINICAL ARTICLE; DOSE RESPONSE; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LUNG METASTASIS; LYMPH NODE METASTASIS; MALE; RECURRENT CANCER; SALIVARY GLAND CARCINOMA; SKIN METASTASIS; SURVIVAL TIME;

ADENOCARCINOMA; ADENOMA, PLEOMORPHIC; ADULT; AGED; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CARCINOMA; CARCINOMA, ADENOID CYSTIC; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; SALIVARY GLAND NEOPLASMS; VINBLASTINE;

EID: 0031739684     PISSN: 00074551     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Kaplan MJ, Johns ME, Cantrell RW. Chemotherapy for salivary gland cancer. Otolaryngol Head Neck Surg 1986; 95: 165-70.
2. Suen JY, Johns ME. Chemotherapy for salivary gland cancer. Laryngoscope 1982; 92: 235-9.
3. Rentschler R, Burgess MA, Byers R. Chemotherapy of malignant major salivary gland neoplasm. A 25-year review of MD Anderson Hospital Experiences. Cancer 1977; 40: 619-24.
4. Romanini A, Surbone A, Ricci S, Conte PF. Phase-II study of continuous infusion of vinorelbine in patients with locally pretreated advanced head and neck cancer. Proc Annu Meet Am Assoc Cancer Res 1993; 34: 1222.
5. Testolin A, Recher C, Pozza F, Panizzoni GA, Gasparini G. Vinorelbine in pre-treated advanced head & neck squamous cell carcinoma: a phase II study. Proc Am Soc Clin Oncol 1994; 13: 289.
6. Alberts DS, Manning MR, Coulthard SW, Koopmann CF, Herman TS. Adriamycin/cis-platinum-cyclophosphamide combination chemotherapy for advanced carcinoma of the parotid gland. Cancer 1981; 47: 645-8.
7. Creagan ET, Woods JE, Shutt AJ, O'Fallon JR. Cyclophosphainicle, adriamycin and cis-diamminedichloroplatinum (II) in the treatment of advanced nonsquamous cell head and neck cancer. Cancer 1983; 52: 2007-10.
8. Dreyfuss AJ, Clark JR, Fallon BG, Posner MR, Norris CM, Miller D. Cyclophosphamide, doxorubicin, and cisplatin combination chemotherapy for advanced carcinomas of salivary gland origin. Cancer 1987; 60: 2869-72.
9. Eisenberg MA. Supporting evidence for an active treatment program for advanced salivary gland carcinomas. Cancer Treat Rep 1985; 69: 319-21.
10. Airoldi M, Brando V, Giordano C, Gabriele P, Bussi M, Cortesina G. Chemotherapy for recurrent salivary gland malignancies: experience of the ENT Department of Turin University. ORL 1994; 56: 105-11.
11. Session RB, Lehane DE, Smith RJH, Bryan N, Suen JY. Intra-arterial cisplatin Treatment of adenoid cystic carcinoma. Arch Otolaryngol 1982; 108: 221-4.
12. Skibba JL, Hurley JD, Ravelo HV. Complete response of a metastatic adenoid cystic carcinoma of the parotid gland to chemotherapy. Cancer 1981; 47: 2543-8.
13. Budd GT, Groppe CW. Adenoid cystic carcinoma of the salivary gland. Sustained complete response to chemotherapy. Cancer 1983; 51: 589-90.
14. Triozzi PL, Brentley A, Fisher S, Cole TB, Crocker I, Huang AT. 5-fluorouracil, cyclophosphamide, and vincristine for adenoid cystic carcinoma of the head and neck. Cancer 1987: 59: 887-90.
15. Venook AP, Tseng A, Meyers FJ, Silverberg J, Boles R, Fu KK, Jacobs CD. Cisplatin, doxorubicin, and 5-fluorouracil chemotherapy for salivary gland malignancies: a pilot study of the Northern California Oncology Group. J Clin Oncol 1987; 5: 951-5.
16. Airoldi M, Pedani F, Brando V, Gabriele P, Giordano C. Cisplatin, epirubicin and 5-fluorouracil combination chemotherapy for recurrent carcinoma of the salivary gland. Tumori 1989; 75: 252-6.
17. Miller AB, Hoogstraten B, Staquet M, Winkler A. Reporting results of cancer treatment. Cancer 1981; 47: 207-14.